Recall of Everest Brand Sambhar Masala and Garam Masala in the U.S. Due to Possible Health Risk - FDA.gov fda.gov Submitted by fdagov3951 on June 30, 2023 at 6:53 PM in business No comments 41
FDA Approves First Gene Therapy for Adults with Severe Hemophilia A - FDA.gov fda.gov Submitted by fdagov3951 on June 29, 2023 at 10:00 PM in business No comments 47
FDA Approves First Cellular Therapy to Treat Patients with Type 1 Diabetes - FDA.gov fda.gov Submitted by fdagov3951 on June 28, 2023 at 10:00 PM in health No comments 32
FDA Launches Pilot Program to Help Reduce Risks Associated with Using Laboratory Developed Tests to Identify Cancer Biomarkers - FDA.gov fda.gov Submitted by fdagov3951 on June 22, 2023 at 1:51 PM in business No comments 55